Digitizing Clinical Trials for Cardiology
The shift to decentralized and hybrid trial designs enables better collection, analysis and management of data and leads to improved patient experience through the use of wearables and patient apps.

Benefit from our ecosystem partnerships
Our vast ecosystem of academic partners is successfully enabling multiple global Phase III trials with a total of more than 15,000 patients, including one of the largest heart failure study programs to date.

Accelerated Recruitment
Global reach to accelerate patient recruitment

Strategic Partners
Partnerships with a consortium of leading experts in Cardiometabolic disease

Site Network
Connection to established site networks for cardiometabolic clinical trials
Trust in our Experience
- We combine thought leadership with operational excellence focused on scientific results rather than box-ticking.
- Bringing a high level of academic engagement to deliver the full suite of trial related services, unlike any traditional contract model.

Suitable Technologies
With our strong technological expertise, we are setting new standards in cardiology research with our integrated, patient-centered and data-driven platform.
Discover Technologies
Let's create an impact. Together.
With our comprehensive approach that combines technological innovation and a deep understanding of clinical research, we are ideally positioned to successfully conduct digital clinical trials in the field of cardiometabolic disease.
Contact us